In this Special Report, expert hematologists review the epidemiology of thrombocytopenia in patients with leukemia and review current and investigational therapies that may help overcome this problem. Medscape Hematology-Oncology
Patient selection for bevacizumab therapy has changed since its FDA approval. In this video blog, Dr. Mark Kris addresses the absolute and relative contraindications to the use of this drug. Medscape Hematology-Oncology
Proteus syndrome is a rare hamartoma syndrome characterized by germline PTEN mutations. How effective is oral rapamycin therapy for its treatment? Nature Clinical Practice Oncology
Dr. Jean-Charles Soria, Scientific Director of the 2011 EMCC, highlights the state of the art of genetic portraiture and personalized medicine. Medscape Hematology-Oncology
This study examined the function of Hes-6 in breast cancer and tested the hypothesis that Hes-6 enhances breast cancer cell proliferation and is regulated by estrogen (E2). Breast Cancer Research